Photo taken from Shushan Hovsepyan/LinkedIn
Jan 12, 2024, 10:42
Shushan Hovsepyan: Ian Tannock compared inhibiting tumor mutations to tree pruning
Shushan Hovsepyan, a Pediatric Oncologist and Clinical Research Coordinator at the Yeolyan Hematology and Oncology Center, shared on X:
“Precision Medicine?
Ian Tannock compared inhibiting tumor mutations to tree pruning: targeting some may not stop the growth, as other parts can still progress.
Despite identifiable genetic profiles being 80%, the response is 1%-30% with matched drugs.“
Read further.
Source: Shushan Hovsepyan/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 08:39
Nov 12, 2024, 23:10